Beida Pharmaceutical Co., Ltd. will apply to the provincial drug bidding and purchasing departments to adjust the price of ectinib before September 20 19, and the adjusted price will be valid until February 3 1 9, 2009. During this period, if the implementation of this agreement is affected by the adjustment of relevant national laws, regulations and policies, both parties will negotiate to change the relevant contents of this agreement or sign a supplementary agreement.
Extended Information 2065438+On April 27th, 2008, the Ministry of Finance, the General Administration of Customs, State Taxation Administration of The People's Republic of China and the State Administration of Pharmaceuticals jointly issued the Notice on the Value-added Tax Policy for Anticancer Drugs, which adjusted the relevant VAT tax policies for anticancer drugs. In order to cooperate with and support the country to implement the follow-up measures of tax reduction for anticancer drugs and further reduce the burden of medical expenses for patients with major diseases, the company participated in special bidding and procurement consultation through price adjustment according to its actual situation.
While implementing the follow-up measures, Chongqing, Anhui, Guangdong, Zhejiang, Tianjin, Hainan, Ningxia, Heilongjiang, Liaoning and other places have issued documents to assess the proportion of drugs negotiated by the state, so as to improve the accessibility of drugs and benefit more patients. In view of the new changes in the business environment, the company will continue to increase the academic promotion of Ectinib, continue to promote the convergence of medical insurance policies in various places, and achieve new growth in sales of Ectinib.
Phoenix Net-Beida Pharmaceutical Co., Ltd. will lower the price of hanging nets in various provinces of Ectinib hydrochloride.